HLA-DRB1 and myeloid sarcoma: There was trend toward an association between HLA DRB1*1501 status in the Controls vs. Progressive MS (p = 0.062) comparison but there was no evidence for a significant association in the Non-progressive vs. Progressive MS (p = 0.84) comparison.